3,3-disubstituted piperidine derivatives and their use as therap

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514320, 514326, 514318, 546 15, 546 16, 546 17, 546 18, 546 19, 546 20, 546193, 546194, A61K 31445, C07D22120

Patent

active

058078657

ABSTRACT:
The present invention relates to compounds of the formula (I) ##STR1## wherein X, Z, R, R.sup.1, R.sup.2, Ar, n and m are as defined herein which are of use in the treatment or prevention of neuropathy, asthma, osteoarthritis, rheumatoid arthritis or migraine.

REFERENCES:
patent: 5340822 (1994-08-01), Emonds-Alt
patent: 5350582 (1994-09-01), Emonds-alts
patent: 5434158 (1995-07-01), Shah
patent: 5559132 (1996-09-01), Miller
patent: 5589489 (1996-12-01), Shenvi
patent: 5635510 (1997-06-01), Burkholder
T. Harrison, wt al., Poster Presentation at Gordon Research Conference on Medicinal Chemistry, Colby Sawyer College, New London, New Hampshire, US (Aug. 4-9, 1996) "High Affinity, Selective Neurokinin 2 and Neurokinin 3 Receptor Antagonists from a Common Structural Template".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3,3-disubstituted piperidine derivatives and their use as therap does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,3-disubstituted piperidine derivatives and their use as therap, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,3-disubstituted piperidine derivatives and their use as therap will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-87662

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.